Bring your project to the BIOPARK ONCOLOGY INCUBATION PROGRAM to make it VC ready

Following the great success of our previous project call in Cell & Gene Therapy, we are now launching an incubation program fully dedicated to Oncology. Joining our BioPark Incubation Oncology Program will provide you access to pre-seed funding & expert advice! Support from academic and industry leaders together with personalized coaching, will make your project VC ready

Now Apply Until September 30^TH

Program Value Proposition

If you are working on an exciting early stage project and looking for funding to generate a compelling proof-of-concept data package, this is the scheme for you. There is up to €500,000 per company available from BSCB’s Butterfly Fund plus non-dilutive financing for three successful applicants. Access to a wealth of expertise from oncology organisations will help you create strong business and development plans.

Following this intensive de-risking process, you’ll have an increased chance of a successful fundraising to take your technology to its next stage of development and patient benefit. There is more detail in the BioPark oncology accelerator program Flyer here

The oncology accelerator program is part of BSCB’s Incubator which has played a role in the formation of 40+ companies, creating 1000+ jobs, and raising over €1,5 billion.

Selected as oncology headquarters by global CMOs such as Catalent, ThermoFisher Scientific and Exothera, Brussels South Charleroi BioPark accounts for 20% of the European oncology manufacturing capacity with a vibrant innovation pipeline. In this new oncology accelerator program, our partners in advanced therapies are coming together to develop the companies of the future.

Franz Obermayr

Program Co-Chairman CEO of Epics Therapeutics

Michel Detheux

Program Co-Chairman CEO of iTeos Therapeutics

Olivier Meyer

Program Director Incubator Head of BSCB Dev

PARTNERING ORGANISATIONS

Criteria for entry

You should be a highly motivated and resilient individual or team, working on a compelling academic or independent oncology research project. You should detail your differentiated approach, preliminary data, support from the literature and area of urgent unmet medical need on the application form here (non-confidential data only at this stage). This should form an exciting story with clear potential patient benefit and a strong case for further development and funding.

Program and timelines

Applications submitted

Applications from March 6 to May 8. Download application form here (fill in with non-confidential information)
Selected longlisted projects

Advisory panel makes initial preselection (Up to 10 projects)
Plan and budget development for selected shortlisted projects

Two-day bootcamp for selected shortlisted projects (first half of July), with final pitch to Butterfly Fund
12-18 month program for successful companies

From May 2023, access to business development training modules, experts from partnering organisations, ULB Open BioLab , regulators and a clinical trial network
Strong proof-of-concept data package & pitch to selected investors

De-risked proposition ready for the next stage of financing - kick-off with opportunity to pitch to our partner VCs and selected potential co-investors
If you want to apply for any of the position then please click on get in touch button

Click on get in touch with us button